Our Response to COVID-19 as Endocrinologists and Diabetologists

J Clin Endocrinol Metab. 2020 May 1;105(5):1299-1301. doi: 10.1210/clinem/dgaa148.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage*
  • Adrenal Insufficiency / complications
  • Angiotensin Receptor Antagonists / adverse effects
  • Angiotensin-Converting Enzyme 2
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / epidemiology*
  • Diabetes Mellitus / virology
  • Endocrine System Diseases / complications
  • Endocrinologists
  • Endocrinology / standards*
  • Glucocorticoids / administration & dosage*
  • Humans
  • Pandemics
  • Peptidyl-Dipeptidase A
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / epidemiology*
  • Practice Guidelines as Topic
  • Receptors, Virus

Substances

  • Adrenal Cortex Hormones
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Glucocorticoids
  • Receptors, Virus
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2